One of the most frequently mutated proto-oncogenes in pRCC, MET, can activate the PI3K-AKT-mTOR and LKB1-AMPK-mTOR nutrient-sensing pathway, which facilitates growth of the tumor [125]. The gene discussed is MTOR; the disease is neoplasm.